Validity of new methods to evaluate renal function in cancer patients treated with cisplatin

PURPOSE: Creatinine clearance (Ccr) is used as a marker of renal function in cancer chemotherapy, but it is not correlated with glomerular filtration rate (GFR) after high-dose cisplatin treatment. In addition to Ccr, measured using 24-h urine collection (24-h Ccr) or Cockcroft–Gault formula (CGF),...

Descripción completa

Detalles Bibliográficos
Autores principales: Funakoshi, Yohei, Fujiwara, Yutaka, Kiyota, Naomi, Mukohara, Toru, Shimada, Takanobu, Toyoda, Masanori, Imamura, Yoshinori, Chayahara, Naoko, Tomioka, Hideo, Umezu, Michio, Otsuki, Naoki, Nibu, Ken-ichi, Minami, Hironobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747994/
https://www.ncbi.nlm.nih.gov/pubmed/26791871
http://dx.doi.org/10.1007/s00280-016-2966-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747994/
https://www.ncbi.nlm.nih.gov/pubmed/26791871
http://dx.doi.org/10.1007/s00280-016-2966-1

Ejemplares similares